Olga Lavynenko
Texas Diabetes Institute(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Liver Disease and Transplantation, Pancreatitis Pathology and Treatment
Most-Cited Works
- → Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( EDICT )(2022)41 cited
- → Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors(2020)33 cited
- → Author response for "Combination Therapy with Pioglitazone/Exenatide Metformin Reduces the Prevalence of Hepatic Fibrosis and Steatosis: The Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes ( EDICT ) Trial"(2022)1 cited
- → Reduced Lipotoxicity Following Triple Therapy for 3 Years in New Onset T2DM(2024)